Lazo-Langner A, Louzada M, Garg A, et al. Assessing the risk-benefit of anticoagulants in elkderly patients with cancer-associated venous thromboembolism; a population based study. EHA 2017, abstract S441.
Duurzame remissies met ivosidenib bij IDH1-gemuteerd gerecidiveerd of refractair AML
jul 2018 | Leukemie